Abstract: A system and method for personalized dosing of a pharmacologic agent include: executing, using a processing device, a plurality of dosing regimen program modules to determine a respective plurality of dose sets in response to receiving, from an input device, a target response value for a patient; and executing, using the processing device, a dosing selection algorithm module, following executing the plurality of dosing regimen program modules and in response to receiving from the input device a response profile and a monitoring frequency of the patient, to determine a recommended dose set computed as a combination of the plurality of dose sets weighted by degrees of matching computed using fuzzy sets and the response profile.

Abstract: The present invention relates to methods for improvement in lower urinary tract function in an individual with neurogenic urological dysfunction through epidural stimulation of the spinal cord. In certain embodiments, the methods comprise applying a pattern of epidural electrical stimulation to the spinal cord of an individual with impaired lower urinary tract under stimulation parameters sufficient to improve the storage of fluid in the bladder, sensations of fullness and/or emptying, detrusor over-activity, high detrusor pressure, voiding the bladder, transitioning from a storage state to a voiding state, and decreasing detrusor-external urethral sphincter dyssynergia. In certain embodiments, additional patterns of epidural electrical stimulation may be applied simultaneously, such as to maintain a normotensive cardiovascular state of the individual.

Abstract: Some embodiments of the invention include inventive compounds (e.g., compounds of Formula (I)). Other embodiments include compositions (e.g., pharmaceutical compositions) comprising the inventive compound. Still other embodiments of the invention include compositions (e.g., pharmaceutical compositions) for treating, for example, certain diseases using the inventive compounds. Some embodiments include methods of using the inventive compound (e.g., in compositions or in pharmaceutical compositions) for administering and treating (e.g., diseases such as cancer). Further embodiments include methods for making the inventive compounds. Additional embodiments of the invention are also discussed herein.

Abstract: Systems and methods for repairing a surface defect in a metallic substrate can have a transducer that generates acoustic energy and an acoustic energy coupling tool connected to the transducer. The acoustic energy coupling tool receives the acoustic energy from the transducer and oscillates at a frequency corresponding to a frequency of the acoustic energy. A filler material is provided within the surface defect and the oscillation of the acoustic energy coupling tool causes a deforming impact of the acoustic energy coupling tool with the filler material within the surface defect, such that the filler material conforms to at least a portion of an internal surface of the surface defect. Additionally, the acoustic energy coupling tool is used to irradiate the filler material while it is being deformed with the acoustic energy.

Abstract: Described are compositions containing quinones that show activity in enhance DNA repair and/or prevent damage to DNA. The quinones are thymoquinone, lapachol, myrtucommulone C, or mixtures thereof, and can be formulated into cosmetic compositions for topical administration to a subject in need thereof. The cosmetic compositions can also include sunscreens, surfactants, sunless tanning agents, desquamation agents, antiperspirants, colorants, preservatives and mixtures; and a cosmetically acceptable carrier. The compositions should find use in methods for treating the signs of ageing in mammals via topical application to the skin or hair of the mammals.

Abstract: Some embodiments of the invention include inventive compounds. Other embodiments include compositions (e.g., pharmaceutical compositions) comprising the inventive compound. Still other embodiments of the invention include compositions (e.g., pharmaceutical compositions) for treating, for example, certain diseases using the compounds. Some embodiments include methods of using the inventive compound (e.g., in compositions or in pharmaceutical compositions) for administering and treating (e.g., diseases such as cancer). Further embodiments include methods for making the inventive compounds. Other embodiments include PFKFB4 inhibitors and methods of using the same that can target neoplastic cells, including, such as, mechanisms within those cells that relate to the use of the glycolytic pathway. In other embodiments, small molecule PFKFB4 inhibitors are used to disrupt the kinase domain of PFKFB4 and, in some instances, decrease the glucose metabolism and growth of human cancers.

Abstract: A system and method for analysis of 3D deformations and regional function of a heart includes: a magnetic resonance imaging (MRI) scanner configured to acquire three tagged volume data series with mutually perpendicular tag lines of a heart; a data storage device in communication with the MRI scanner and configured to store the three tagged volume data series; and an image processing machine in communication with data storage device. The image processing machine is configured to: model an intensity distribution around each voxel of each tagged volume data series as a moving sine wave front with a local frequency and an amplitude; and determine a phase and frequency for each voxel from the local frequency and amplitude and a displacement from a quotient of a phase difference and the local frequency.

Abstract: Systems and methods for diagnosing prostate cancer. Image sets (e.g., MRI collected at one or more b-values) and biological values (e.g., prostate specific antigen (PSA)) have features extracted and integrated to produce a diagnosis of prostate cancer. The image sets are analyzed primarily in three steps: (1) segmentation, (2) feature extraction, smoothing, and normalization, and (3) classification. The biological values are analyzed primarily in two steps: (1) feature extraction and (2) classification. Each analysis results in diagnostic probabilities, which are then combined to pass through an additional classification stage. The end result is a more accurate diagnosis of prostate cancer.

Abstract: A method for the rapid and controlled synthesis of mixed metal oxide nanoparticles using relatively low temperature plasma oxidation of liquid droplets of predetermined mixed metal precursors is disclosed. The resulting nanoparticles reflect the metal precursor stoichiometries and the mixed metal oxide's metastable phase can be controlled. The synthesis of mixed transition metal oxide comprising binary metal oxides, ternary mixed metal oxides, quaternary mixed metal oxides and pentanary mixed metal oxides are demonstrated herein.

Abstract: Some embodiments of the invention include methods of using a compound (e.g., Formula (I)) for the reduction of carbon dioxide to formate by contacting the carbon dioxide with a composition comprising a compound. In certain embodiments, the source of the carbon dioxide is air or is flue gas. Additional embodiments of the invention are also discussed herein.

Abstract: Protein complex variants, compositions, and methods of use thereof are provided. The protein complex variant includes a cholera toxin B subunit variant having one or more modifications thereto. The method of use thereof includes treating a disease by administering an effective amount of a composition including a cholera toxin B subunit variant to a subject in need thereof.

Abstract: A method and system of automated segmentation of an anatomical object through learned examples include: receiving, by a processing device, an image of the anatomical object; determining a sparse representation of a shape of the anatomical object by iteratively evolving a segmenting surface as a combination of a level set segmentation and a linear combination of training shapes; and outputting, to an output device, the sparse representation of the shape of the anatomical object as the segmentation of the anatomical object.

Abstract: A method of fabricating a dental restoration is provided that includes the initial step of providing a powder of a dental material. An amount of a binder is then selectively deposited onto the powder of the dental material to produce an unfinished layer of the dental material. Multiple layers of the dental material are then produced by continually providing a powder of dental material and selectively depositing an amount of a binder until a three-dimensional unfinished model is produced. The unfinished model is then separated from an amount of unaffected powder, and is sintered to produce a three-dimensional dental restoration having a functionally-graded structure.

Abstract: A laryngoscope with integrated and controllable suction includes a handle and a blade. A suction port is at the proximal end of the handle and is configured for connection to an air source. The suction port defines an opening into one or more air flow paths defined through the laryngoscope, which each terminate at one or more intake ports. In some embodiments, a valve is interposed into each air flow path to regulate air flow along each air flow path. Such a valve is operably connected to a switch mounted on an exterior surface of the laryngoscope, such that manipulation of the switch causes the valve to open or close, thus allowing the physician or other medical professional to control the air flow and selectively apply constant or intermittent suction.

Abstract: A perovskite thin film and method of forming a perovskite thin film are provided. The perovskite thin film includes a substrate, a hole blocking/electron transport layer, and a sintered perovskite layer. The method of forming the perovskite solar cell includes depositing a perovskite layer onto a substrate and processing (for example, by sintering) the perovskite layer with intense pulsed light to initiate a radiative thermal response that is enabled by an alkyl halide additive.

Abstract: Some embodiments of the invention include inventive catalysts (e.g., compounds of Formula (I) or (Ia)). Other embodiments include compositions comprising the inventive catalysts. Some embodiments include methods of using the inventive catalysts (e.g., in hydrofluorination of an organic compound). Further embodiments include methods for making the inventive catalysts. Additional embodiments of the invention are also discussed herein.

Abstract: Methods for treating alcohol induced liver injury include administering to a subject an effective amount of a ginger-derived nanoparticle. Methods for decreasing nuclear factor erythroid-2 related factor (Nrf2) activation in a hepatocyte are also provided and include contacting the hepatocyte with an effective amount of a ginger-derived nanoparticle. Pharmaceutical preparations including ginger-derived nanoparticles are further provided.

Abstract: Embodiments of the present invention relate to methods for applying epidural electrical stimulation to improve motor function or physiological responses in paralyzed individuals. More particularly, the present invention relates to methods for creating and applying specific configurations of epidural stimulation to assist or cause a patient to perform a complex motor function or to mitigate one or more secondary consequences of paralysis including, but not limited to, cardiovascular, respiratory, bladder, temperature and sexual dysfunction.

Abstract: Compositions comprising a therapeutic agent encapsulated by an edible plant-derived microvesicle are provided. Methods of treating an inflammatory disorder and methods of treating a cancer are further provided and include administering an effective amount of a composition comprising a therapeutic agent encapsulated by an edible plant-derived microvesicle to a subject. Further provided are methods of diagnosing a colon cancer that include the steps of administering an edible plant-derived microvesicle incorporating a detectable label to a subject and then determining an amount of the detectable label in an intestine of the subject.

Abstract: Methods and systems for producing a structure having selectable piezoelectric properties via additive manufacturing. Such methods can include coupling an ultrasound generating device to a print head of the additive manufacturing apparatus; transmitting acoustic energy from the ultrasound generating device to the print head to vibrate the print head in an oscillatory manner; extruding a feed material from the print head; moving the print head in at least one dimension relative to a substrate on which the structure is being manufactured; and dispensing layers sequentially on top of each other to form the structure. Such systems can include an additive manufacturing apparatus comprising a print head movable in at least one dimension relative to a base configured to support the structure being produced; and an ultrasound generating device that is connected to the print head.